Come up with a name for your new list and we'll add to it:
SOLX raised a round of funding on May 17, 2002. Investors include
Boston University Technology Development.
SOLX has developed a surgical laser and method of treatment for glaucoma, the second most common cause of blindness in the elderly. SOLX's DeepLight Glaucoma Treatment System is being developed to pro…